Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.
In an earlier study the scientists showed that out of 1,574 deaths, 49 individuals had died from side effects of medicines. Now they have analyzed how many of these deaths could have been prevented. The researchers estimate that seven of the cases, 14 percent, might possibly have been avoided if the drug had been replaced or the dosage lowered. If the results are representative for the entire country, this means that roughly 400 people could be saved each year.
"The reason we can draw this conclusion is that we made a randomized selection among people who died in the region," says researcher and pharmacist Anna Jönsson, project director at the Nordic School of Public Health in Gothenburg.
Most of the preventable deaths were caused by pain-relieving substances, and by drugs that inhibit the formation of blood clots, but also by blood-pressure-reducing pharmaceuticals.
"In the 'definitely preventable' cases, something clearly went wrong in the care process, such as the patient receiving a drug that was counterindicated or was prescribed at an excessively high dosage," says Katja Hakkarainen, a pharmacist and doctoral candidate at NHV.
A chain of mistakes, organizational causes, such as lack of personnel, and long workdays probably contribute to side effects from drugs. Therefore there must be a system for crosschecking that would reveal any mistakes that were made. Healthcare personnel make mistakes sometimes, but so do patients. These mistakes , too, can be caught if sufficiently careful follow-ups are in place.
To avoid unnecessary deaths, the researchers suggest more and better education in pharmacology. Better support for those issuing prescriptions that provides relevant information about the side effects of drugs, and better routines for following up are concrete measures that the scientists believe could improve the statistics.
Anna K Jönsson adds, however, that that it must be borne in mind that most of the deceased persons included in the study were older individuals, which means that the conclusion is that drug side effects have contributed to their death. Various concepts have been used, and when it comes to the "possibly preventable cases," the judgment is that the healthcare personnel could have done something more, such as carrying out more frequent follow-ups of the effects of the drugs.
The research team has studied deaths during 2001 in Jönköping, Kalmar, and Östergötland counties in three respects. "Incidence of fatal adverse drug reactions: a population based study" was published in 2007. "Fatal drug poisonings in a Swedish general population" came out in January 2009, and now the study "Preventable drug related mortality in a Swedish population" has been accepted by Pharmacoepedimiology and Drug Safety. Those taking part in this part of the study are Henrik Druid, Katja M Hakkarainen (NHV), Staffan Hägg, Anna K Jönsson (NHV), Karin Wester, Anne Hiselius, Olav Spigset, and Mikaela Tjäderborn.Contact: Anna K Jönsson e-mail: email@example.com Phone: +46 (0)31 693989
Monica Bengtson | idw
Antarctic Ice Sheet mass loss has increased
14.06.2018 | Technische Universität Dresden
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences